Sidova Veronika, Zoufaly Pavel, Pokorny Jan, Dzubak Petr, Hajduch Marian, Popa Igor, Urban Milan
Department of Organic Chemistry, Faculty of Science, Palacky University, Olomouc, Czech Republic.
Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
PLoS One. 2017 Feb 3;12(2):e0171621. doi: 10.1371/journal.pone.0171621. eCollection 2017.
In this work, we describe synthesis of conjugates of betulinic acid with substituted triazoles prepared via Huisgen 1,3-cycloaddition. All compounds contain free 28-COOH group. Allylic bromination of protected betulinic acid by NBS gave corresponding 30-bromoderivatives, their substitution with sodium azides produced 30-azidoderivatives and these azides were subjected to CuI catalysed Huisgen 1,3-cycloaddition to give the final conjugates. Reactions had moderate to high yields. All new compounds were tested for their in vitro cytotoxic activities on eight cancer and two non-cancer cell lines. The most active compounds were conjugates of 3β-O-acetylbetulinic acid and among them, conjugate with triazole substituted by benzaldehyde 9b was the best with IC50 of 3.3 μM and therapeutic index of 9.1. Five compounds in this study had IC50 below 10 μM and inhibited DNA and RNA synthesis and caused block in G0/G1 cell cycle phase which is highly similar to actinomycin D. It is unusual that here prepared 3β-O-acetates were more active than compounds with the free 3-OH group and this suggests that this set may have common mechanism of action that is different from the mechanism of action of previously known 3β-O-acetoxybetulinic acid derivatives. Benzaldehyde type conjugate 9b is the best candidate for further drug development.
在本研究中,我们描述了通过惠斯根1,3-环加成反应制备的桦木酸与取代三唑共轭物的合成。所有化合物均含有游离的28-COOH基团。用N-溴代丁二酰亚胺对保护的桦木酸进行烯丙基溴化反应得到相应的30-溴衍生物,它们与叠氮化钠反应生成30-叠氮衍生物,这些叠氮化物经碘化亚铜催化的惠斯根1,3-环加成反应得到最终的共轭物。反应产率为中等至较高。所有新化合物均在八种癌细胞系和两种非癌细胞系上进行了体外细胞毒性活性测试。活性最高的化合物是3β-O-乙酰桦木酸的共轭物,其中,被苯甲醛取代的三唑共轭物9b最佳,IC50为3.3 μM,治疗指数为9.1。本研究中的五种化合物IC50低于10 μM,抑制DNA和RNA合成,并导致G0/G1细胞周期阶段阻滞,这与放线菌素D高度相似。不同寻常的是,此处制备的3β-O-乙酸酯比具有游离3-OH基团的化合物更具活性,这表明该系列化合物可能具有与先前已知的3β-O-乙酰氧基桦木酸衍生物不同的共同作用机制。苯甲醛型共轭物9b是进一步药物开发的最佳候选物。